Existing research indicates that TCM, through its multi-component and multi-target mechanisms, can modulate the tumor microenvironment, enhance immune cell functionality, and exert a synergistic anti-tumor effect when used alongside PD-1/PD-L1 inhibitors. The gene discussed is CD274; the disease is neoplasm.